首页 正文

Erlotinib in non-small cell lung cancer's second line treatment. Clinical case

{{output}}
Male, of 58 years, caucasian, construction worker, non smoker, with depressive syndrome, biliary lithiasis, renal cysts, surgery for benign intestinal polyps and relevant familiar history - aunt with lung cancer and mother with colon cancer. He initiated thora... ...